SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001535610-17-000079
Filing Date
2017-04-13
Accepted
2017-04-13 15:05:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G DMPI 4.13.17 dmpi0417.txt SC 13G 13639
  Complete submission text file 0001535610-17-000079.txt   15250
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Subject) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-87181 | Film No.: 17760423
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G